CD4 News and Research

RSS
SARS-CoV-2 N501Y mutation adversely affects cellular immune response

SARS-CoV-2 N501Y mutation adversely affects cellular immune response

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

POSTECH researchers discover mechanism behind intestinal epithelial lymphocyte differentiation

POSTECH researchers discover mechanism behind intestinal epithelial lymphocyte differentiation

Experimental intranasal influenza vaccine produces durable immune response

Experimental intranasal influenza vaccine produces durable immune response

Long COVID-19 symptoms not associated with reduced cell-mediated immunity, finds study

Long COVID-19 symptoms not associated with reduced cell-mediated immunity, finds study

Researchers explore adaptive immunity against human coronaviruses

Researchers explore adaptive immunity against human coronaviruses

Researchers develop ‘next-generation vaccine platform’ against SARS-CoV-2

Researchers develop ‘next-generation vaccine platform’ against SARS-CoV-2

Study provides a detailed look at vulnerable sites on SARS-CoV-2

Study provides a detailed look at vulnerable sites on SARS-CoV-2

People with severe COVID-19 cases may have more protective "memory" T cells

People with severe COVID-19 cases may have more protective "memory" T cells

FDA approves first injectable, complete regimen for HIV-1 infection in adults

FDA approves first injectable, complete regimen for HIV-1 infection in adults

High factor V levels linked to lymphopenia and weakened immunity in severe COVID-19

High factor V levels linked to lymphopenia and weakened immunity in severe COVID-19

Lower CD4 T cell reactivity to seasonal coronaviruses found in healthcare workers with COVID-19

Lower CD4 T cell reactivity to seasonal coronaviruses found in healthcare workers with COVID-19

NK and T cell subsets show distinctive lung-homing receptor profiles in COVID-19 patients

NK and T cell subsets show distinctive lung-homing receptor profiles in COVID-19 patients

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Study investigates effect of anti-CD45 RIT lymphodepletion on immune cell types

Study investigates effect of anti-CD45 RIT lymphodepletion on immune cell types

The mystery of Giglio island’s resistance to COVID-19

The mystery of Giglio island’s resistance to COVID-19

Severe COVID-19 recovered patients do not display long-lasting adaptive immune responses, finds study

Severe COVID-19 recovered patients do not display long-lasting adaptive immune responses, finds study

Adaptive immune system against COVID-19 can last for at least eight months

Adaptive immune system against COVID-19 can last for at least eight months